Anticorps Polyclonal de lapin anti-FBXO21

FBXO21 Polyclonal Antibody for IF/ICC, IP, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat

Applications

IF/ICC, IP, ELISA

Conjugaison

Non conjugué

N° de cat : 17648-1-AP

Synonymes

F box only protein 21, F box protein 21, F-box only protein 21, FBX21, FBXO 21



Applications testées

Résultats positifs en IPcellules A549, tissu cérébral de rat
Résultats positifs en IF/ICCcellules A549,

Dilution recommandée

ApplicationDilution
Immunoprécipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

17648-1-AP cible FBXO21 dans les applications de IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, rat

Réactivité Humain, rat
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène FBXO21 Protéine recombinante Ag11882
Nom complet F-box protein 21
Masse moléculaire calculée 537 aa, 63 kDa
Poids moléculaire observé75 kDa
Numéro d’acquisition GenBankBC034045
Symbole du gène FBXO21
Identification du gène (NCBI) 23014
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

FBXO21 (F-box protein 21) is a member of the F-box protein family and serves as the substrate recognition component of the SCF (Skp1-Cullin-F-box) E3 ubiquitin ligase complex. In AML cells, FBXO21 can ubiquitinate p85α, a regulatory subunit of the PI3K pathway, leading to its degradation. This reduces PI3K signaling, promotes p85α dimerization, and activates ERK, thereby influencing cell proliferation and survival. Silencing FBXO21 in AML cells induces differentiation, inhibits tumor progression, and increases sensitivity to chemotherapeutic agents. FBXO21 can regulate immune responses by ubiquitinating and degrading proteins like ASK1 through pro-inflammatory cytokine pathways. It can also ubiquitinate p85α, affecting CXCL10 expression and modulating immune cell infiltration and anti-tumor activity. In renal cell carcinoma, overexpression of FBXO21 significantly suppresses ccRCC cell proliferation and metastasis both in vitro and in vivo. It may be related to the stromal score and the infiltration levels of immune cells associated with prognosis. Additionally, FBXO21 overexpression increases the expression of key molecules in the CREB pathway.

Protocole

Product Specific Protocols
IF protocol for FBXO21 antibody 17648-1-APDownload protocol
IP protocol for FBXO21 antibody 17648-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}